Kellerhals Carrard advised Vifor Pharma on this transaction. Vifor Pharma Participations AG (Vifor Pharma) closed its divestment transaction regarding its finished drug product manufacturing business with...
You must be a Standard 1 Year member to access this content.
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to STILLE in this transaction. Stille AB, a medical device company whose shares are listed on the Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...
You must be a Standard 1 Year member to access this content.
